Skip to main content
Truhout big pharma

Before COVID-19, Big Pharma Was Neglecting Vaccine and Antiviral Research

Drug companies have historically pleased investors by promoting vaccine development programs during disease outbreaks, then quietly dropping them later, according to Dana Brown, director of The Next System Project, a research and development lab for political-economic alternatives. Despite an outbreak raging in the Republic of Congo, the British drug maker GlaxoSmithKline recently gave up its effort to develop a vaccine for Ebola and handed off its research to a nonprofit lab. Ebola is deadly but relatively rare globally, and the market was too small to generate significant profits. In 2017, the massive French drug maker Sanofi pulled out of a partnership with the U.S. Army to develop a vaccine for the mosquito-borne Zika virus.

Read the entire article at Truthout.

Publication date: 2020-04-23
Parent publication: Truthout
Publication URL: https://truthout.org/articles/before-covid-19-big-pharma-was-neglecting-vaccine-and-antiviral-research/

More related work

September 27, 2020
Default Image

39 Health Systems Declare: It is Undeniable, Racism is a Public Health Crisis

39 health systems in 45 states and Washington, DC commit to addressing racism and the public health disparities caused by racism.

read more
August 31, 2020
Default Image

Climate Justice Fellow

Climate Justice Fellow The Democracy Collaborative is seeking a Climate Justice Fellow to provide support to the Climate & Energy Team and advance its mission to manage a just transition off extractive, fossil fuels and design pathways towards a clean energy system based on energy democracy

read more
August 17, 2020
Default Image

Fall Research Intern

NOTE: The deadline for this application was 9/14/20 and the application window is now closed. We are currently reviewing applications and will be in touch with candidates soon. Research Internship The Democracy Collaborative is hiring for a part-time, paid intern position focused on providing

read more